image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Spire Healthcare - Shares close in on £4

November 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SPI
  • Price:
  • 395p
Shares in Spire have surged towards £4 on chatter that Mediclinic, fresh from purchasing Al Noor Hospitals and which acquired a 29.9% stake in Spire in June ’15, wants to take over the whole company. A director purchase of 121,000 shares at 390p on 21st September hasn’t harmed sentiment either.Spire, which operates 38 private hospitals, 12 clinics and two specialist cancer centres across the UK, released interims that were slightly ahead of expectations. Revenues rose 5% to £470m on an underlying basis while operating profit excluding disposals rose 2% to £59.7m. Cash flow is so strong that even with capital expenditure increasing 91% to £72m, net debt only rose 1% to £427m.Across the ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X